P

Prime Medicine
D

PRME

3.34500
USD
0.03
(0.75%)
Market Closed
Volume
18,674
EPS
-2
Div Yield
-
P/E
-2
Market Cap
438,733,016
News

Title: Prime Medicine

Sector: Healthcare
Industry: Biotechnology
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.